{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:30:32Z","timestamp":1785328232846,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.advms.2026.03.006","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:13:59Z","timestamp":1774487639000},"page":"130-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bone marrow involvement in breast cancer: a retrospective cohort study"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4799-9611","authenticated-orcid":false,"given":"Dawid","family":"Sigorski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Wilk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Michalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Pieniuk-Faszy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zygmunt","family":"Kozielec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Lebiedzi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2026.03.006_bib1","first-page":"287","article-title":"Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN","volume":"5","author":"Zhang","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.advms.2026.03.006_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.breast.2013.10.005","article-title":"Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy","volume":"23","author":"Rossi","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.advms.2026.03.006_bib3","first-page":"41","article-title":"Metastatic disease of the breast and local recurrence of breast cancer","volume":"31","author":"Lloyd Davies","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.advms.2026.03.006_bib4","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO clinical practice guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.advms.2026.03.006_bib5","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/s41379-020-0615-z","article-title":"Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution","volume":"33","author":"Chen","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.advms.2026.03.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crad.2014.08.015","article-title":"Metastatic patterns of breast cancer subtypes: what radiologists should know in the era of personalized cancer medicine","volume":"70","author":"Chikarmane","year":"2015","journal-title":"Clin Radiol"},{"key":"10.1016\/j.advms.2026.03.006_bib7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/tbj.13647","article-title":"Factors affecting survival and treatment efficacy in breast cancer patients with bone marrow metastasis","volume":"26","author":"Sakin","year":"2020","journal-title":"Breast J"},{"key":"10.1016\/j.advms.2026.03.006_bib8","article-title":"Symptomatic bone marrow involvement in breast cancer \u2013 clinical presentation, treatment, and prognosis: a single institution review of 22 cases","volume":"31","author":"Kopp","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.advms.2026.03.006_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.clon.2008.08.005","article-title":"Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies","volume":"20","author":"Amir","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1016\/j.advms.2026.03.006_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5603\/OCP.2018.0034","article-title":"Recommendations for testing of predictive marker HER2 in patients with invasive breast cancer. Recommendations in accordance with American Society of Clinical Oncology (ASCO) guidelines from 30th May 2018","volume":"14","author":"Marsza\u0142ek","year":"2018","journal-title":"Oncol Clin Pract"},{"key":"10.1016\/j.advms.2026.03.006_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1042773","article-title":"Symptomatic bone marrow metastases in breast cancer: a retrospective cohort study","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.advms.2026.03.006_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2021.06.028","article-title":"Disseminated tumour cells from the bone marrow of early breast cancer patients: results from an international pooled analysis","volume":"154","author":"Hartkopf","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.advms.2026.03.006_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.semnuclmed.2024.10.008","article-title":"Diagnosing bone metastases in breast cancer: a systematic review and network meta-analysis on diagnostic test accuracy studies of 2-[18F]FDG-PET\/CT, 18F-NaF-PET\/CT, MRI, contrast-enhanced CT, and bone scintigraphy","volume":"55","author":"Gerke","year":"2025","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.advms.2026.03.006_bib14","doi-asserted-by":"crossref","first-page":"10672","DOI":"10.1002\/cam4.5827","article-title":"Clinicopathological features and prognosis of breast cancer combined with symptomatic bone marrow metastases: a 10-year, single-center, real-world study of 67 cases","volume":"12","author":"Niu","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.advms.2026.03.006_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s13193-021-01377-7","article-title":"Bone marrow metastases from solid organ cancer in adults","volume":"12","author":"Arya","year":"2021","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.advms.2026.03.006_bib16","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.21873\/anticanres.15099","article-title":"Successful stabilization of symptomatic bone marrow metastasis two times in a breast cancer patient","volume":"41","author":"Akagi","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.advms.2026.03.006_bib17","first-page":"28","article-title":"Stabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicin","volume":"3","author":"Pahouja","year":"2015","journal-title":"Cancer Treat Commun"},{"key":"10.1016\/j.advms.2026.03.006_bib18","article-title":"Symptomatic bone marrow metastasis in triple-negative breast cancer: a case report and literature review","volume":"15","author":"Zheng","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.advms.2026.03.006_bib19","author":"Gnanaraj"},{"key":"10.1016\/j.advms.2026.03.006_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.achaem.2017.05.001","article-title":"Metastasis of solid tumors into bone marrow \u2013 single center experience","volume":"48","author":"Ko\u0142da","year":"2017","journal-title":"Acta Haematol Pol"},{"key":"10.1016\/j.advms.2026.03.006_bib21","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.advms.2026.03.006_bib22","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American society of clinical oncology\/College of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.advms.2026.03.006_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104516","article-title":"Prognostic significance of receptor conversion following neoadjuvant therapy in breast cancer: a systematic review & meta-analysis","volume":"82","author":"Dowling","year":"2025","journal-title":"Breast"},{"key":"10.1016\/j.advms.2026.03.006_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-021-06390-6","article-title":"Prognostic significance of receptor expression discordance between primary and recurrent breast cancers: a meta-analysis","volume":"191","author":"Shiino","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.advms.2026.03.006_bib25","doi-asserted-by":"crossref","unstructured":"Caswell-Jin JL, Mcnamara K, Reiter JG, Sun R, Hu Z, Ma Z, et al. Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy n.d. https:\/\/doi.org\/10.1038\/s41467-019-08593-4.","DOI":"10.1038\/s41467-019-08593-4"},{"key":"10.1016\/j.advms.2026.03.006_bib26","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.3390\/cells9122644","article-title":"Hormone receptor loss in breast cancer: molecular mechanisms, clinical settings, and therapeutic implications","volume":"9","author":"Zattarin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.advms.2026.03.006_bib27","article-title":"A study on the impact of neoadjuvant therapy on molecular subtype conversion in breast cancer","volume":"23","author":"Zhang","year":"2025","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.advms.2026.03.006_bib28","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1016\/j.annonc.2024.08.195","article-title":"252P evolution of breast cancer biological subtypes between pre-treatment biopsy and residual disease after neoadjuvant therapy","volume":"35","author":"Pogoda","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.advms.2026.03.006_bib29","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1200\/JCO.2011.37.2482","article-title":"Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression","volume":"30","author":"Lindstr\u00f6m","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.advms.2026.03.006_bib30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4103\/0377-4929.138728","article-title":"The prognostic significance of bone marrow metastases: evaluation of 58 cases","volume":"57","author":"Kucukzeybek","year":"2014","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.advms.2026.03.006_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/tbj.12264","article-title":"Prognostic evaluation of breast cancer patients with evident bone marrow metastasis","volume":"20","author":"Demir","year":"2014","journal-title":"Breast J"},{"key":"10.1016\/j.advms.2026.03.006_bib32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1751-553X.2007.00947.x","article-title":"Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors","volume":"30","author":"Aksoy","year":"2008","journal-title":"Int J Lab Hematol"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112626000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112626000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:40:13Z","timestamp":1779090013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112626000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1896112626000155"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2026.03.006","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow involvement in breast cancer: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2026.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Medical University of Bialystok. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}